[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Alzheimer's Disease Drug Market Professional Survey Report 2017

October 2017 | 101 pages | ID: G9A3304B11BWEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Alzheimer's Disease Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Allergan
  • Eisai
  • Novartis
  • Daiichi Sankyo
  • Merz Pharma
  • Pfizer
  • Johnson & Johnson
  • Lundbeck.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Donepezil
  • Memantine
  • Rivastigmine
By Application, the market can be split into
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Alzheimer's Disease Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ALZHEIMER'S DISEASE DRUG

1.1 Definition and Specifications of Alzheimer's Disease Drug
  1.1.1 Definition of Alzheimer's Disease Drug
  1.1.2 Specifications of Alzheimer's Disease Drug
1.2 Classification of Alzheimer's Disease Drug
  1.2.1 Donepezil
  1.2.2 Memantine
  1.2.3 Rivastigmine
1.3 Applications of Alzheimer's Disease Drug
  1.3.1 Hospital Pharmacy
  1.3.2 Retail Pharmacy
  1.3.3 Online Pharmacy
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ALZHEIMER'S DISEASE DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug
2.3 Manufacturing Process Analysis of Alzheimer's Disease Drug
2.4 Industry Chain Structure of Alzheimer's Disease Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ALZHEIMER'S DISEASE DRUG

3.1 Capacity and Commercial Production Date of Global Alzheimer's Disease Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Alzheimer's Disease Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Alzheimer's Disease Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Alzheimer's Disease Drug Major Manufacturers in 2016

4 GLOBAL ALZHEIMER'S DISEASE DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Alzheimer's Disease Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Alzheimer's Disease Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Alzheimer's Disease Drug Sales and Growth Rate Analysis
  4.3.2 2016 Alzheimer's Disease Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Alzheimer's Disease Drug Sales Price
  4.4.2 2016 Alzheimer's Disease Drug Sales Price Analysis (Company Segment)

5 ALZHEIMER'S DISEASE DRUG REGIONAL MARKET ANALYSIS

5.1 North America Alzheimer's Disease Drug Market Analysis
  5.1.1 North America Alzheimer's Disease Drug Market Overview
  5.1.2 North America 2012-2017E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Alzheimer's Disease Drug Sales Price Analysis
  5.1.4 North America 2016 Alzheimer's Disease Drug Market Share Analysis
5.2 China Alzheimer's Disease Drug Market Analysis
  5.2.1 China Alzheimer's Disease Drug Market Overview
  5.2.2 China 2012-2017E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Alzheimer's Disease Drug Sales Price Analysis
  5.2.4 China 2016 Alzheimer's Disease Drug Market Share Analysis
5.3 Europe Alzheimer's Disease Drug Market Analysis
  5.3.1 Europe Alzheimer's Disease Drug Market Overview
  5.3.2 Europe 2012-2017E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Alzheimer's Disease Drug Sales Price Analysis
  5.3.4 Europe 2016 Alzheimer's Disease Drug Market Share Analysis
5.4 Southeast Asia Alzheimer's Disease Drug Market Analysis
  5.4.1 Southeast Asia Alzheimer's Disease Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Alzheimer's Disease Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Alzheimer's Disease Drug Market Share Analysis
5.5 Japan Alzheimer's Disease Drug Market Analysis
  5.5.1 Japan Alzheimer's Disease Drug Market Overview
  5.5.2 Japan 2012-2017E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Alzheimer's Disease Drug Sales Price Analysis
  5.5.4 Japan 2016 Alzheimer's Disease Drug Market Share Analysis
5.6 India Alzheimer's Disease Drug Market Analysis
  5.6.1 India Alzheimer's Disease Drug Market Overview
  5.6.2 India 2012-2017E Alzheimer's Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Alzheimer's Disease Drug Sales Price Analysis
  5.6.4 India 2016 Alzheimer's Disease Drug Market Share Analysis

6 GLOBAL 2012-2017E ALZHEIMER'S DISEASE DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Alzheimer's Disease Drug Sales by Type
6.2 Different Types of Alzheimer's Disease Drug Product Interview Price Analysis
6.3 Different Types of Alzheimer's Disease Drug Product Driving Factors Analysis
  6.3.1 Donepezil of Alzheimer's Disease Drug Growth Driving Factor Analysis
  6.3.2 Memantine of Alzheimer's Disease Drug Growth Driving Factor Analysis
  6.3.3 Rivastigmine of Alzheimer's Disease Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ALZHEIMER'S DISEASE DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Alzheimer's Disease Drug Consumption by Application
7.2 Different Application of Alzheimer's Disease Drug Product Interview Price Analysis
7.3 Different Application of Alzheimer's Disease Drug Product Driving Factors Analysis
  7.3.1 Hospital Pharmacy of Alzheimer's Disease Drug Growth Driving Factor Analysis
  7.3.2 Retail Pharmacy of Alzheimer's Disease Drug Growth Driving Factor Analysis
  7.3.3 Online Pharmacy of Alzheimer's Disease Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ALZHEIMER'S DISEASE DRUG

8.1 Allergan
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Allergan 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Allergan 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.2 Eisai
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Eisai 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Eisai 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.3 Novartis
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Novartis 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Novartis 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.4 Daiichi Sankyo
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Daiichi Sankyo 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Daiichi Sankyo 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.5 Merz Pharma
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Merz Pharma 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Merz Pharma 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.6 Pfizer
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Pfizer 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Pfizer 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.7 Johnson & Johnson
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Johnson & Johnson 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Johnson & Johnson 2016 Alzheimer's Disease Drug Business Region Distribution Analysis
8.8 Lundbeck.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Lundbeck. 2016 Alzheimer's Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Lundbeck. 2016 Alzheimer's Disease Drug Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ALZHEIMER'S DISEASE DRUG MARKET

9.1 Global Alzheimer's Disease Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Alzheimer's Disease Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Alzheimer's Disease Drug Sales Price Forecast
9.2 Alzheimer's Disease Drug Regional Market Trend
  9.2.1 North America 2017-2022 Alzheimer's Disease Drug Consumption Forecast
  9.2.2 China 2017-2022 Alzheimer's Disease Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Alzheimer's Disease Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Alzheimer's Disease Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Alzheimer's Disease Drug Consumption Forecast
  9.2.6 India 2017-2022 Alzheimer's Disease Drug Consumption Forecast
9.3 Alzheimer's Disease Drug Market Trend (Product Type)
9.4 Alzheimer's Disease Drug Market Trend (Application)

10 ALZHEIMER'S DISEASE DRUG MARKETING TYPE ANALYSIS

10.1 Alzheimer's Disease Drug Regional Marketing Type Analysis
10.2 Alzheimer's Disease Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Alzheimer's Disease Drug by Region
10.4 Alzheimer's Disease Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ALZHEIMER'S DISEASE DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ALZHEIMER'S DISEASE DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Picture of Alzheimer's Disease Drug
Table Product Specifications of Alzheimer's Disease Drug
Table Classification of Alzheimer's Disease Drug
Figure Global Production Market Share of Alzheimer's Disease Drug by Type in 2016
Figure Donepezil Picture
Table Major Manufacturers of Donepezil
Figure Memantine Picture
Table Major Manufacturers of Memantine
Figure Rivastigmine Picture
Table Major Manufacturers of Rivastigmine
Table Applications of Alzheimer's Disease Drug
Figure Global Consumption Volume Market Share of Alzheimer's Disease Drug by Application in 2016
Figure Hospital Pharmacy Examples
Table Major Consumers in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Major Consumers in Retail Pharmacy
Figure Online Pharmacy Examples
Table Major Consumers in Online Pharmacy
Figure Market Share of Alzheimer's Disease Drug by Regions
Figure North America Alzheimer's Disease Drug Market Size (Million USD) (2012-2022)
Figure China Alzheimer's Disease Drug Market Size (Million USD) (2012-2022)
Figure Europe Alzheimer's Disease Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Alzheimer's Disease Drug Market Size (Million USD) (2012-2022)
Figure Japan Alzheimer's Disease Drug Market Size (Million USD) (2012-2022)
Figure India Alzheimer's Disease Drug Market Size (Million USD) (2012-2022)
Table Alzheimer's Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug in 2016
Figure Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure Industry Chain Structure of Alzheimer's Disease Drug
Table Capacity and Commercial Production Date of Global Alzheimer's Disease Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Alzheimer's Disease Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Alzheimer's Disease Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Alzheimer's Disease Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Alzheimer's Disease Drug 2012-2017
Figure Global 2012-2017E Alzheimer's Disease Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Alzheimer's Disease Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Alzheimer's Disease Drug Capacity and Growth Rate
Table 2016 Global Alzheimer's Disease Drug Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Alzheimer's Disease Drug Sales (K Units) and Growth Rate
Table 2016 Global Alzheimer's Disease Drug Sales (K Units) List (Company Segment)
Table 2012-2017E Global Alzheimer's Disease Drug Sales Price (USD/Unit)
Table 2016 Global Alzheimer's Disease Drug Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Alzheimer's Disease Drug 2012-2017E
Figure North America 2012-2017E Alzheimer's Disease Drug Sales Price (USD/Unit)
Figure North America 2016 Alzheimer's Disease Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Alzheimer's Disease Drug 2012-2017E
Figure China 2012-2017E Alzheimer's Disease Drug Sales Price (USD/Unit)
Figure China 2016 Alzheimer's Disease Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Alzheimer's Disease Drug 2012-2017E
Figure Europe 2012-2017E Alzheimer's Disease Drug Sales Price (USD/Unit)
Figure Europe 2016 Alzheimer's Disease Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Alzheimer's Disease Drug 2012-2017E
Figure Southeast Asia 2012-2017E Alzheimer's Disease Drug Sales Price (USD/Unit)
Figure Southeast Asia 2016 Alzheimer's Disease Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Alzheimer's Disease Drug 2012-2017E
Figure Japan 2012-2017E Alzheimer's Disease Drug Sales Price (USD/Unit)
Figure Japan 2016 Alzheimer's Disease Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Alzheimer's Disease Drug 2012-2017E
Figure India 2012-2017E Alzheimer's Disease Drug Sales Price (USD/Unit)
Figure India 2016 Alzheimer's Disease Drug Sales Market Share
Table Global 2012-2017E Alzheimer's Disease Drug Sales (K Units) by Type
Table Different Types Alzheimer's Disease Drug Product Interview Price
Table Global 2012-2017E Alzheimer's Disease Drug Sales (K Units) by Application
Table Different Application Alzheimer's Disease Drug Product Interview Price
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2016 Allergan Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Allergan Alzheimer's Disease Drug Business Region Distribution
Table Eisai Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eisai Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eisai Alzheimer's Disease Drug Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novartis Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Alzheimer's Disease Drug Business Region Distribution
Table Daiichi Sankyo Information List
Table Product A Overview
Table Product B Overview
Table 2016 Daiichi Sankyo Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Daiichi Sankyo Alzheimer's Disease Drug Business Region Distribution
Table Merz Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merz Pharma Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merz Pharma Alzheimer's Disease Drug Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Alzheimer's Disease Drug Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Alzheimer's Disease Drug Business Region Distribution
Table Lundbeck. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Lundbeck. Alzheimer's Disease Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Lundbeck. Alzheimer's Disease Drug Business Region Distribution
Figure Global 2017-2022 Alzheimer's Disease Drug Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Alzheimer's Disease Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Alzheimer's Disease Drug Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Alzheimer's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Alzheimer's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Alzheimer's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Alzheimer's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Alzheimer's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Alzheimer's Disease Drug Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Alzheimer's Disease Drug by Type 2017-2022
Table Global Consumption Volume (K Units) of Alzheimer's Disease Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Alzheimer's Disease Drug by Region


More Publications